CIRM's Financial Status, $500 Million Lending Program on the Table
Directors of the California stem cell agency next week will discuss how to run its ambitious and novel $500 million plan to lend money to the state's riskiest biotech ventures as well as the agency's own finances in the light of the Golden State's budget crisis.
The meeting of the Finance Subcommittee is scheduled for Jan. 21 at eight teleconference loc…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.